Astrazeneca Regulatory News (AZN)

Resolution

Votes for

% of votes cast

Votes against

% of votes cast

Votes cast in total

Total votes cast as a % of issued share capital

Votes withheld

1

To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021

1,203,570,226

99.85

1,828,274

0.15

1,205,398,500

77.79

5,547,341

2

To confirm dividends

1,193,597,088

98.93

12,920,907

1.07

1,206,517,995

77.87

4,366,330

3

To reappoint PricewaterhouseCoopers LLP as Auditor

1,198,088,929

99.29

8,509,251

0.71

1,206,598,180

77.87

4,347,248

4

To authorise the Directors to agree the remuneration of the Auditor

1,204,954,300

99.87

1,563,462

0.13

1,206,517,762

77.87

4,311,513

5a

To re-elect Leif Johansson as a Director

1,166,282,927

96.68

40,088,832

3.32

1,206,371,759

77.86

4,573,789

5b

To re-elect Pascal Soriot as a Director

1,205,673,389

99.93

863,219

0.07

1,206,536,608

77.87

4,408,995

5c

To elect Aradhana Sarin as a Director

1,204,771,723

99.86

1,661,294

0.14

1,206,433,017

77.86

4,512,437

5d

To re-elect Philip Broadley as a Director

1,191,418,997

98.75

15,054,946

1.25

1,206,473,943

77.86

4,471,514

5e

To re-elect Euan Ashley as a Director

1,205,615,431

99.93

843,877

0.07

1,206,459,308

77.86

4,486,117

5f

To re-elect Michel Demaré as a Director

1,159,460,793

96.34

44,030,272

3.66

1,203,491,065

77.67

7,453,982

5g

To re-elect Deborah DiSanzo as a Director

1,199,445,587

99.98

245,001

0.02

1,199,690,588

77.43

11,254,771

5h

To re-elect Diana Layfield as a Director

1,206,239,742

99.98

251,612

0.02

1,206,491,354

77.87

4,454,103

5i

To re-elect Sheri McCoy as a Director

1,199,985,750

99.46

6,515,562

0.54

1,206,501,312

77.87

4,444,145

5j

To re-elect Tony Mok as a Director

1,205,526,446

99.92

961,584

0.08

1,206,488,030

77.86

4,457,427

5k

To re-elect Nazneen Rahman as a Director

1,192,803,495

98.87

13,681,523

1.13

1,206,485,018

77.86

4,460,509

5l

To elect Andreas Rummelt as a Director

1,205,642,938

99.93

816,947

0.07

1,206,459,885

77.86

4,485,572

5m

To re-elect Marcus Wallenberg as a Director

979,070,782

81.15

227,477,101

18.85

1,206,547,883

77.87

4,397,534

6

To approve the Annual Report on Remuneration for the year ended 31 December 2021

1,109,853,237

92.23

93,486,120

7.77

1,203,339,357

77.66

7,606,290

7

To authorise limited political donations

1,176,840,533

97.53

29,853,717

2.47

1,206,694,250

77.88

4,261,968

8

To authorise the Directors to allot shares

1,112,092,040

92.70

87,623,060

7.30

1,199,715,100

77.43

11,230,323

9

To authorise the Directors to disapply pre-emption rights

1,193,005,130

99.11

10,731,935

0.89

1,203,737,065

77.69

7,206,669

10

To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments

1,175,775,085

97.67

27,999,631

2.33

1,203,774,716

77.69

7,088,425

11

To authorise the Company to purchase its own shares

1,195,870,775

99.15

10,230,544

0.85

1,206,101,319

77.84

4,843,802

12

To reduce the notice period for general meetings

1,062,882,097

88.11

143,446,819

11.89

1,206,328,916

77.85

4,616,168

13

To extend the AstraZeneca PLC 2012 Savings Related Share Option Scheme

1,200,174,255

99.53

5,676,533

0.47

1,205,850,788

77.82

5,094,639